The findings in this study indicate that subcutaneous administration of NMN prevented the diabetes-induced decrease in NAD+ levels, normalized SIRT1 protein levels, and improved downstream activities such as mitochondrial respiration and deacetylation of proteins, which are mediated by NAD+, to protect CNS neurons from diabetes-induced neurodegeneration. The gene discussed is SIRT1; the disease is diabetes mellitus.